Ironwood Pharmaceuticals | IRWD - Przychody Ze Sprzedaży





Obroty Zmiana Data
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Almirall EUR 602.71M 55.09M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amarin USD 49.22M 451K 2025-12
Ardelyx USD 94.47M 30.74M 2026-03
Astellas Pharma JPY 537.93B 33.28B 2026-03
AstraZeneca USD 15.38B 90M 2026-06
Charles River Laboratories USD 995.8M 1.6M 2026-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Halozyme Therapeutics USD 377M 74.76M 2026-03
Incyte USD 1.67B 400M 2026-06
Ironwood Pharmaceuticals USD 106.51M 58.8M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
MacroGenics USD 20.8M 20.43M 2026-03
Moderna USD 100M 289M 2026-06
Myriad Genetics USD 190.7M 9.7M 2026-06
Pacira USD 177M 19.87M 2026-03
PTC Therapeutics USD 361M 88M 2026-06
Puma Biotechnology USD 80.54M 33.46M 2024-09
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Takeda JPY 1.22T 130B 2026-06
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12